Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SLN compared with ALEC: revenue, margins and what each company keeps, and the suppliers and customers both name
SLN
Silence Therapeutics plc
Change
Mkt cap
Revenue
Revenue
ALEC
Alector, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
SLN
Silence Therapeutics plc
vs
ALEC
Alector, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
SLN
No earnings history for SLN.
ALEC
1 of 3
at or beyond implied
Report
implied
realized
× implied
Nov 6 '26
—
▲
+9.57%
—
Q2 FY26
±39.7%
▼
−2.73%
×0.07
May 8 '26
±13.1%
▼
−13.93%
×1.06
Q1 FY26
±31.5%
▲
+7.11%
×0.23
= implied
SLN realized, solid
ALEC realized, hatched
One scale, both sides: full bar = 40%
× = |realized| ÷ implied
Source: market data
SLN
Silence Therapeutics plc
Change
19.73
▲
+0.03%
· post 19.73
Mkt cap
$932.2M
Revenue
$422,000
Q1 FY26
Revenue
$559,000
FY25
ALEC
Alector, Inc.
Change
2.29
▲
+9.63%
· post 2.26
Closed
Nov 6 '26
Mkt cap
$340.9M
Revenue
$163M
Q3 FY26
Revenue
$21M
FY25
vs
Compare
Closed
Nov 6 '26
SLN
Silence Therapeutics plc
vs
ALEC
Alector, Inc.
19.73
▲
+0.03%
post 19.73
Price
2.29
▲
+9.63%
post 2.26
$932.2M
Mkt cap
$340.9M
Q1 FY26
$422,000
Revenue
$163M
Q3 FY26
FY25
$559,000
Revenue
$21M
FY25
Change
Change
SLN
19.73
▲
+0.03%
vs
ALEC
2.29
▲
+9.63%
Closed
Nov 6 '26